Drug Type Small molecule drug |
Synonyms JX21108 |
Target |
Mechanism PfHDAC1 inhibitors(Plasmodium falciparum HDAC1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H25N7O2 |
InChIKeyXYBGCCKUMXSCIP-UHFFFAOYSA-N |
CAS Registry2484124-18-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malaria | Preclinical | CN | 11 Dec 2020 |